Cancer drugs launched over the last 12 years generated roughly $50bn in sales in 2017 and a cumulative $179bn during that time, highlighting just how important the therapeutic area is to the drug industry – and how pivotal it is poised to remain.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?